Evidence map›Paper›PMID 32047793›Full record

ArticleWorld journal of clinical cases2020

Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report.

Hua-Fei Chen, Wen-Xian Wang, Xiao-Feng Li, Li-Xin Wu, You-Cai Zhu, Kai-Qi Du, Chun-Wei Xu

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Salivary Exosomes in Health and Disease: Future Prospects in the Eye.International journal of molecular sciences · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hua-Fei ChenThoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing 314000, Zhejiang Province, China.
Wen-Xian WangDepartment of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China.
Xiao-Feng LiThoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing 314000, Zhejiang Province, China.
Li-Xin WuThoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing 314000, Zhejiang Province, China.
You-Cai ZhuThoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing 314000, Zhejiang Province, China.
Kai-Qi DuThoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing 314000, Zhejiang Province, China.
Chun-Wei XuDepartment of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, Fujian Province, China. xuchunweibbb@163.com.
Fujian Medical University · CNFujian Provincial Cancer Hospital · CNZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe eye is a rare site for lung cancer metastasis. Indeed, ocular metastasis is one of the greatest challenges to quality of life in a cancer patient. Here we present a patient with lung adenocarcinoma and ocular metastasis. CASE SUMMARY: The patient was a 70-year-old man diagnosed with lung adenocarcinoma who developed eye metastasis mimicking anterior scleritis. Brain magnetic resonance imaging showed an abnormal signal in the right eye. Based on next generation sequencing of the surgical specimen, the patient was shown to have a

conclusionMultidiscipline expertise collaboration is needed to make the early diagnosis and determine the prompt treatment in patients. We hope to increase the awareness of the possibility of lung cancer metastasizing to the eye.

Indexed as

Case reportEyeKRAS mutationMetastasesNon-small cell lung cancer

Identifiers

PMID32047793
PMCPMC7000956
OpenAlexW2999172282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.